MAPT and Alzheimer disease: This includes the general consensus that Aβ pathology that starts in the human neocortex 10–15 years before AD becomes symptomatic, and hippocampal tau pathology (which coincides with early stages of symptomatic AD in humans), together, underlie AD onset [2].